(Q36766628)

16 August 2017

1 reference

title

The current state of infection with respiratory syncytial virus in the setting of congenital cardiac malformations (English)

1 reference

16 August 2017

0 references

4

Gil Wernovsky

1 reference

16 August 2017

Timothy F Feltes

1

1 reference

16 August 2017

Richard L Hodinka

series ordinal

2

1 reference

16 August 2017

Stephen M Paridon

series ordinal

3

1 reference

16 August 2017

Henry M Sondheimer

series ordinal

5

1 reference

16 August 2017

publication date

1 September 2006

1 reference

16 August 2017

published in

Cardiology in the Young

1 reference

16 August 2017

volume

16 Suppl 3

1 reference

16 August 2017

page(s)

136-143

1 reference

Lung epithelial fluid transport and the resolution of pulmonary edema

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

Increased fragility of pulmonary capillaries in newborn rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

Respiratory syncytial virus and parainfluenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Early ribavirin treatment of respiratory syncytial viral infection in high-risk children

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Rates of hospitalization for respiratory syncytial virus infection among children in medicaid

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Respiratory syncytial viral infection in infants with congenital heart disease

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Systemic corticosteroids in infant bronchiolitis: A meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Growth and development of the lung

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncytial virus-associated bronchiolitis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Effects of an aorticopulmonary shunt on lung fluid balance in the young lamb.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Bronchiolitis in infants

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Advances in the laboratory diagnosis of viral respiratory disease

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Effect of outflow pressure on lung lymph flow in unanesthetized sheep

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Prediction of duration of hospitalization in respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Development of lung edema: interstitial fluid dynamics and molecular structure.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951106001077

7 January 2021

10.1017/S1047951106001077

Identifiers

DOI

1 reference

release_w2jb54ypwvhihlxfdletnl5z2y

16 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w2jb54ypwvhihlxfdletnl5z2y

24 November 2022

mapped directly with Wikidata item

1 reference